News & Announcements | NIH Common Fund

News & Announcements

Wednesday, Dec 18, 2019

1st autologous IPS cell clinical trial for vision loss in the US

The researchers will take a patient’s own blood cells, and in a lab, convert them into iPS cells capable of becoming any type of cell in the body. The iPS cells are then programmed to become retinal pigment epithelial cells, the type of cell that dies early in the geographic atrophy form of AMD. NEI.

Monday, Dec 16, 2019

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina

This page last reviewed on November 6, 2024

Scroll To Top